Julien Mazières, MD, PhD, is pulmonologist and an oncologist, heading the thoracic oncology program at Toulouse University Hospital in France and Toulouse Cancer Institute (IUCT). He also serves as a professor of pulmonology there. He is a researcher at Institut National de la Santé et de la Recherche Médicale (INSERM) in the Oncology Research Center of Toulouse (CRCT, UMR1037).
Professor Mazières received his medical degree in Toulouse and completed specialty training in pulmonology and oncology at the University of Toulouse, where he also earned a master’s degree in molecular and cellular biology, and a doctoral degree at Paul Sabatier University, also in Toulouse. He has work as a research fellow in thoracic oncology lab in San Francisco (UCSF).
His main research interests are early diagnosis, targeted therapy, immunotherapy and multimodal treatment for lung cancer, mesothelioma, and thymoma. He is also involved in translational research related to lung cancer in women and in prognostic and predictive biomarkers. In his research for INSERM, Professor Mazières is working on fundamental cancer research with a special focus on RhoGTPAses, tumor invasion and resistance to targeted therapy.
His work has been published in more than 140 peer-reviewed publications including The Lancet, The Lancet Oncology, the Journal of Clinical Oncology, and Cancer Research.